Incremental cost-effectiveness of screening migrant groups for the ten countries of origin with the highest number of infected HBV and HCV cases in the Netherlandsa.</p
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
Background and Aims: The epidemiology of hepatitis B in Europe is changing, with migration causing s...
We evaluated uptake and diagnostic outcomes of voluntary hepatitis B (HBV) and C virus (HCV) screeni...
BackgroundChronic infection with hepatitis B or C virus (HBV/HCV) can progress to cirrhosis, liver c...
Chronic infection with hepatitis B or C virus (HBV/HCV) can progress to cirrhosis, liver cancer, and...
OBJECTIVE: We aimed to assess the cost-effectiveness of hepatitis C virus (HCV) screening strategies...
BACKGROUND & AIMS: Persons with chronic hepatitis B virus (HBV) infection are at risk of developing ...
Maximum investment (€2016) allowed per migrant to achieve cost-effective combined HBV/HCV screening ...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
In the Netherlands vaccination against hepatitis B has up to now targeted risk groups such as homose...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
Background and Aims: The epidemiology of hepatitis B in Europe is changing, with migration causing s...
We evaluated uptake and diagnostic outcomes of voluntary hepatitis B (HBV) and C virus (HCV) screeni...
BackgroundChronic infection with hepatitis B or C virus (HBV/HCV) can progress to cirrhosis, liver c...
Chronic infection with hepatitis B or C virus (HBV/HCV) can progress to cirrhosis, liver cancer, and...
OBJECTIVE: We aimed to assess the cost-effectiveness of hepatitis C virus (HCV) screening strategies...
BACKGROUND & AIMS: Persons with chronic hepatitis B virus (HBV) infection are at risk of developing ...
Maximum investment (€2016) allowed per migrant to achieve cost-effective combined HBV/HCV screening ...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
In the Netherlands vaccination against hepatitis B has up to now targeted risk groups such as homose...
Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area...
Background and Aims: The epidemiology of hepatitis B in Europe is changing, with migration causing s...
We evaluated uptake and diagnostic outcomes of voluntary hepatitis B (HBV) and C virus (HCV) screeni...